CAHO and Orchid Pharma partnership kicks off with conference on antimicrobial resistance
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
The emergence of new infections in India is a growing concern
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
The conference is also expected to pave the way for nations to come out with bold and specific political commitments in the 2024 UN General Assembly High-Level Meeting on AMR
The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.
The meeting was co-organized by World Health Organization’s Country Office for India, World Animal Protection India and ReAct Asia Pacific
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
Reinforcing commitment to ethical and sustainable growth
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
Subscribe To Our Newsletter & Stay Updated